Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
The summary for the Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional): The purpose of this Notice of Funding Opportunity (NOFO) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability.
| Federal Grant Title: | Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PAR-23-216 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.859 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | September 30th, 2025 |
| Original Application Deadline: | September 30th, 2025 |
| Posted Date: | July 11th, 2023 |
| Creation Date: | July 11th, 2023 |
| Archive Date: | November 5th, 2025 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | July 11th, 2023 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
- • Maximizing Access to Research Careers (MARC) (T34)
- • Medical Scientist Training Program (MSTP) (T32)
- • Single Source: The NIGMS Human Genetic Cell Repository (U42 - Clinical Trial Not Allowed)
- • Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial ...
- • Tools for Genetic and Genomic Studies in Emerging Model Organisms
- • Evolution of Infectious Diseases
- • Mbrs Support of Continuous Research Excellence (Score)
- More Grants from the National Institutes of Health
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/U...
- • ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/U...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01...
- • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...